Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Jacobson

Showing results (401-410 of 599) with videos related to

Pageof 60
Sort By:
Cells|December 19, 2019
Adenosine A<sub>1</sub>-A<sub>2A</sub> Receptor-Receptor Interaction: Contribution to Guanosine-Mediated EffectsDébora Lanznaster, Caio M Massari, Vendula Marková, et al.
Journal of Medicinal Chemistry|November 23, 2011
Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptorFrancesca Deflorian, T Santhosh Kumar, Khai Phan, et al.
Collection of Czechoslovak Chemical Communications|November 24, 2021
NUCLEOSIDE PRODRUGS OF A<sub>3</sub> ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTSPedro Besada, Liaman K Mamedova, Krishnan K Palaniappan, et al.
Pharmacological Research|December 14, 2011
Anti-ischemic effects of multivalent dendrimeric A₃ adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heartBella Chanyshev, Asher Shainberg, Ahuva Isak, et al.
Journal of Medicinal Chemistry|September 20, 2002
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundaryZhan-Guo Gao, Soo-Kyung Kim, Thibaud Biadatti, et al.
The Journal of Experimental Medicine|August 27, 2003
Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptorsHolger K Eltzschig, Juan C Ibla, Glenn T Furuta, et al.
Molecular Pharmacology|May 4, 2016
Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 ReceptorJo-Anne Baltos, Silvia Paoletta, Anh T N Nguyen, et al.
Biochemical Pharmacology|October 13, 2004
Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptorMarco Cattaneo, Anna Lecchi, Michihiro Ohno, et al.
Purinergic Signalling|July 6, 2013
P2Y2 receptor agonist with enhanced stability protects the heart from ischemic damage in vitro and in vivoEdith Hochhauser, Ronit Cohen, Maayan Waldman, et al.
Biochemical Pharmacology|January 7, 2018
A binding kinetics study of human adenosine A<sub>3</sub> receptor agonistsLizi Xia, Athina Kyrizaki, Dilip K Tosh, et al.
Pageof 60

Showing results (401-410 of 599) with videos related to

Sort By:
Pageof 60
Cells|December 19, 2019
Adenosine A<sub>1</sub>-A<sub>2A</sub> Receptor-Receptor Interaction: Contribution to Guanosine-Mediated EffectsDébora Lanznaster, Caio M Massari, Vendula Marková, et al.
Journal of Medicinal Chemistry|November 23, 2011
Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptorFrancesca Deflorian, T Santhosh Kumar, Khai Phan, et al.
Collection of Czechoslovak Chemical Communications|November 24, 2021
NUCLEOSIDE PRODRUGS OF A<sub>3</sub> ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTSPedro Besada, Liaman K Mamedova, Krishnan K Palaniappan, et al.
Pharmacological Research|December 14, 2011
Anti-ischemic effects of multivalent dendrimeric A₃ adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heartBella Chanyshev, Asher Shainberg, Ahuva Isak, et al.
Journal of Medicinal Chemistry|September 20, 2002
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundaryZhan-Guo Gao, Soo-Kyung Kim, Thibaud Biadatti, et al.
The Journal of Experimental Medicine|August 27, 2003
Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptorsHolger K Eltzschig, Juan C Ibla, Glenn T Furuta, et al.
Molecular Pharmacology|May 4, 2016
Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 ReceptorJo-Anne Baltos, Silvia Paoletta, Anh T N Nguyen, et al.
Biochemical Pharmacology|October 13, 2004
Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptorMarco Cattaneo, Anna Lecchi, Michihiro Ohno, et al.
Purinergic Signalling|July 6, 2013
P2Y2 receptor agonist with enhanced stability protects the heart from ischemic damage in vitro and in vivoEdith Hochhauser, Ronit Cohen, Maayan Waldman, et al.
Biochemical Pharmacology|January 7, 2018
A binding kinetics study of human adenosine A<sub>3</sub> receptor agonistsLizi Xia, Athina Kyrizaki, Dilip K Tosh, et al.
Pageof 60